209 lines
No EOL
11 KiB
HTML
209 lines
No EOL
11 KiB
HTML
<!-- Changed ON 09/24/2024 -->
|
|
<!-- Google Tag Manager -->
|
|
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
|
|
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
|
|
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
|
|
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
|
|
})(window,document,'script','dataLayer','GTM-T2DH393N');</script>
|
|
<!-- End Google Tag Manager -->
|
|
|
|
|
|
|
|
|
|
|
|
<HTML lang="en-US">
|
|
|
|
<!-- From NoticeTemplate.txt -->
|
|
|
|
|
|
|
|
|
|
<HEAD>
|
|
|
|
|
|
<TITLE>Expired NOT-TR-20-012: Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)</TITLE>
|
|
|
|
|
|
<META NAME="description" CONTENT="NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) NOT-TR-20-012. NCATS">
|
|
<META NAME="Keywords" CONTENT="NOT-TR-20-012: Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)">
|
|
<meta name="viewport" content="width=device-width, initial-scale=1.0">
|
|
<link href="../guide_styles/css/bootstrap.min.css" rel="stylesheet" media="screen">
|
|
<link href="../guide_styles/css/style.css" rel="stylesheet" media="screen">
|
|
<link href="../guide_styles/css/FOAM_Style.css" rel="stylesheet">
|
|
|
|
|
|
|
|
</HEAD>
|
|
|
|
<BODY>
|
|
|
|
|
|
<link type="text/css" href="../guide_styles/css/expired.css" rel="stylesheet" media="all">
|
|
<div class="noticeBar">This notice has expired. Check the <a href="https://grants.nih.gov/funding/searchguide/">NIH Guide</a> for active opportunities and notices.</div>
|
|
<div id="watermark_background">
|
|
<p id="watermark_text">EXPIRED</p>
|
|
</div>
|
|
|
|
|
|
|
|
|
|
|
|
<div class="container">
|
|
<div class="row">
|
|
<div class="col-xs-12">
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<span class="title">Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)</span>
|
|
|
|
<hr noshade>
|
|
|
|
<p><span class="heading3">Notice Number:</span>
|
|
<span class="title">NOT-TR-20-012</span></p>
|
|
|
|
<p><span class="heading3">Key Dates</span><br>
|
|
<strong>Release Date:</strong> March 27, 2020<br>
|
|
<strong>First Available Due Date: </strong> June 05, 2020<br>
|
|
<strong> Expiration Date: </strong> October 17, 2020</p>
|
|
<span class="heading3">Related Announcements</span><br>
|
|
<p><a href="https://grants.nih.gov/grants/guide/pa-files/par-17-465.html" target="_blank">PAR-17-465</a> Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)</p>
|
|
<p><a href="https://grants.nih.gov/grants/guide/pa-files/par-18-462.html" target="_blank">PAR-18-462</a> Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trial Not Allowed)</p>
|
|
<p><a href="https://grants.nih.gov/grants/guide/pa-files/par-18-332.html" target="_blank">PAR-18-332</a> Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required)</p>
|
|
<p><span class="heading3">Issued by</span><br>
|
|
National Center for Advancing Translational Sciences (<a href="https://ncats.nih.gov/" target="_blank">NCATS</a>)</p>
|
|
<p class="heading2">Purpose</p>
|
|
<div>
|
|
<p>National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel coronavirus (<a name="_Hlk35339470">SARS-CoV-2</a>) and the disease it causes, i.e., “coronavirus disease 2019” (COVID-19). NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial.</p>
|
|
<p><a name="_Hlk34992545">The hypothesis for proposed studies must be developed using innovative processes to identify the therapeutic/indication pair. Examples include the following:</a></p>
|
|
<ul>
|
|
<li><a name="_Hlk35240748">Testing a publicly posted therapeutic candidate for use to treat </a>COVID-19. Examples include clinical candidate therapeutics in documents publicly posted by the World Health Organization (<a href="https://apps.who.int/iris/bitstream/handle/10665/330680/WHO-HEO-RDBlueprint%28nCoV%29-2020.1-eng.pdf?ua=1" target="_blank" Title="Link to Non-U.S. Government Site">types/classes of candidate therapeutics</a>) and (<a href="https://www.who.int/blueprint/priority-diseases/key-action/Roadmap-version-FINAL-for-WEB.pdf?ua=1" target="_blank" Title="Link to Non-U.S. Government Site">candidates for clinical evaluation</a>).</li>
|
|
</ul>
|
|
<ul>
|
|
<li>Testing a candidate therapy to treat COVID-19 that was already identified with a publicly available computational approach.</li>
|
|
</ul>
|
|
<ul>
|
|
<li><a name="_Hlk34992469">Testing of existing therapeutic candidates that work on mechanistic targets shared among other viruses that may be relevant to SARS-CoV-2.</a></li>
|
|
</ul>
|
|
<p>NCATS is soliciting applications to PAR-17-465, PAR-18-462, and PAR-18-332.</p>
|
|
<p><strong>Background</strong></p>
|
|
<p>Many existing experimental drugs, FDA approved drugs, and biologics already have been tested in humans, and detailed information is available about their pharmacology, formulation, and potential toxicity. By building upon previous research and development efforts, new uses for existing drugs or biologics can be advanced to testing in clinical trials more quickly than starting from scratch. If a new therapy receives regulatory approval, it can be efficiently integrated into clinical practice. Coronaviruses are a diverse family of viruses that cause a range of disease in humans and animals, and there are currently no approved coronavirus therapeutics. In January 2020, a novel coronavirus, SARS-CoV-2, was identified as the causative agent of an outbreak of viral pneumonia. Transmission characteristics and the associated morbidity and mortality are not completely understood, but there is clear evidence of human-to-human transmission. Many other aspects of the disease are poorly understood. Given this, there is an urgent public health need to better understand COVID-19 and find therapies to treat infections.</p>
|
|
<p> </p>
|
|
<p><strong>Application and Submission Information</strong></p>
|
|
<p>This notice applies to receipt dates shown below.</p>
|
|
<p>Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.</p>
|
|
<table width="639">
|
|
<tbody>
|
|
<tr>
|
|
<td valign="bottom" width="96"><p align="center"><strong>Activity Codes</strong></p></td>
|
|
<td valign="bottom" width="336"><p align="center"><strong>FOA Title</strong></p></td>
|
|
<td valign="bottom" width="208"><p align="center"><strong>Applicable Dates</strong></p></td>
|
|
</tr>
|
|
<tr>
|
|
<td valign="top" width="96"><p>UG3/UH3</p></td>
|
|
<td valign="top" width="336"><p><a href="https://grants.nih.gov/grants/guide/pa-files/par-17-465.html" target="_blank">PAR-17-465</a>: Bench Testing Therapeutic/Indication Paring Strategies (UG3/UH3)</p></td>
|
|
<td valign="top" width="208"><p>Applicable Receipt Date:</p>
|
|
<ul>
|
|
<li>June 26, 2020</li>
|
|
</ul></td>
|
|
</tr>
|
|
<tr>
|
|
<td valign="top" width="96"><p>U34</p></td>
|
|
<td valign="top" width="336"><p><a href="https://grants.nih.gov/grants/guide/pa-files/par-18-462.html" target="_blank">PA-18-462</a>:Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trial Not Allowed)</p></td>
|
|
<td valign="top" width="208"><p>Applicable Receipt Date:</p>
|
|
<ul>
|
|
<li>June 16, 2020</li>
|
|
<li>October 16, 2020</li>
|
|
</ul></td>
|
|
</tr>
|
|
<tr>
|
|
<td valign="top" width="96"><p>U01</p></td>
|
|
<td valign="top" width="336"><p><a href="https://grants.nih.gov/grants/guide/pa-files/par-18-332.html" target="_blank">PAR-18-332</a>: Clinic Testing Therapeutic/Indications Pairing Strategies (U01 Clinical Trial Required)</p></td>
|
|
<td valign="top" width="208"><p>Applicable Receipt Dates:</p>
|
|
<ul>
|
|
<li>June 5, 2020</li>
|
|
<li>October 5, 2020</li>
|
|
</ul></td>
|
|
</tr>
|
|
</tbody>
|
|
</table>
|
|
<p>All instructions in the <a href="https://grants.nih.gov/grants/how-to-apply-application-guide.html" target="_blank">SF424 (R&R) Application Guide</a> and the funding opportunity announcement used for submission must be followed, with the following additions:</p>
|
|
<ul>
|
|
<li>For funding consideration, applicants must include “NOT-TR-20-012” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.</li>
|
|
</ul>
|
|
</div>
|
|
<div></div>
|
|
<div></div>
|
|
<div>Applications nonresponsive to terms of this NOSI will be not be considered for the NOSI initiative.</div>
|
|
<p> </p>
|
|
<p class="heading2">Inquiries</p>
|
|
<p>Please direct all inquiries to the Scientific/Research, Peer Review, and Financial/Grants Management contacts in Section VII of the listed funding opportunity announcements.</p>
|
|
<p> </p>
|
|
|
|
|
|
|
|
|
|
|
|
</div>
|
|
</div>
|
|
|
|
|
|
<div class="row">
|
|
<div class="col-xs-12">
|
|
<P>
|
|
<HR>
|
|
<A HREF="/grants/guide/WeeklyIndex.cfm?03-27-20">Weekly TOC for this Announcement</A><br>
|
|
<A HREF="/grants/guide/index.html">NIH Funding Opportunities and Notices</A>
|
|
<hr>
|
|
</div>
|
|
</div>
|
|
<link rel="stylesheet" type="text/css" media="print" href="css/notices_print.css " />
|
|
|
|
|
|
|
|
|
|
|
|
<div class="row">
|
|
<div class="footer">
|
|
|
|
<div class="col-sm-4"> <a href="/grants/oer.htm"><img src="/images7/nih-oer-logo.jpg" alt="NIH Office of Extramural Research Logo" usemap="#Map2" border="0"></a>
|
|
<map name="Map2" id="Map2">
|
|
<area shape="rect" coords="89,17,359,39" href="http://www.nih.gov" />
|
|
<area shape="rect" coords="91,39,286,58" href="http://grants.nih.gov/grants/oer.htm" />
|
|
<area shape="rect" coords="3,5,78,55" href="http://grants.nih.gov/grants/oer.htm" />
|
|
</map>
|
|
</div>
|
|
<div class="col-sm-4">
|
|
<div style="float:left; padding: 5 5 5 70"> <a href="https://www.hhs.gov/"><img src="/images7/dhhs_sm.gif" width="36" height="37" border="0" alt="Department of Health and Human Services (HHS) - Home Page" long desc="Logo, circular in shape, depicting an American eagle in-flight with stylized profiles of human faces appearing on the trailing edge of the wings. The perimeter of the logo is encircled with the words 'Department of Health and Human Services U S A'"></a></div>
|
|
<div style="padding: 5 5 5 5;">Department of Health<br>
|
|
and Human Services (HHS)</div>
|
|
</div>
|
|
<div class="col-sm-4">
|
|
<div style="padding: 5 5 5 0" align="center"> <a href="https://www.usa.gov/"><img src="/images7/USA_Gov_logo.gif" border="0" alt="USA.gov - Government Made Easy" long desc="Logo,- the words 'USA.gov - Government Made Easy' with single streaking star above the logo"></a> </div>
|
|
</div>
|
|
</div>
|
|
</div>
|
|
|
|
|
|
<div class="row">
|
|
<div class="footer">
|
|
<div class="col-xs-12" align="center" style="padding: 20 5 5 5"> <span style="color:#6E6E6E; font-size:1.0em; font-family: 'Trebuchet MS', Arial, Helvetica, sans-serif">NIH... Turning Discovery Into Health<sup>®</sup></span> </div>
|
|
</div>
|
|
</div>
|
|
|
|
|
|
<div class="row">
|
|
<div class="footer">
|
|
<div class="col-xs-12" align="center">
|
|
|
|
</div>
|
|
</div>
|
|
</div>
|
|
|
|
</div>
|
|
|
|
</BODY>
|
|
</HTML> |